Federica Maritati Selected Research

Retroperitoneal Fibrosis

10/2021	Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis.
1/2020	Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients.
1/2019	Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients.
3/2018	Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis.
1/2018	[18F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis.
6/2017	Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.
9/2013	Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.
7/2012	Rituximab therapy for chronic periaortitis.
6/2011	CC chemokine receptor 5 polymorphism in chronic periaortitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Federica Maritati Research Topics

Disease

9	Retroperitoneal Fibrosis 10/2021 - 06/2011
8	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2021 - 01/2014
6	Vasculitis (Vasculitides) 01/2021 - 03/2012
4	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 03/2012
3	Glomerulonephritis 05/2021 - 10/2020
3	Immunoglobulin G4-Related Disease 01/2020 - 11/2018
2	Infections 05/2021 - 01/2014
2	Disease Progression 01/2021 - 09/2017
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 10/2020 - 01/2018
2	Ureteral Obstruction 01/2019 - 07/2016
2	Proteinuria 01/2018 - 01/2017
2	Asthma (Bronchial Asthma) 01/2014 - 03/2012
2	Eosinophilia 01/2014 - 03/2012
1	False Aneurysm (Pseudoaneurysm) 07/2022
1	Pathologic Constriction (Stenosis) 07/2022
1	Acute Kidney Injury (Acute Renal Failure) 07/2022
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Hemorrhage 01/2022
1	Thrombosis (Thrombus) 05/2021
1	COVID-19 05/2021
1	Viral Pneumonia 05/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2021
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2020
1	Purpura 10/2020
1	Neoplasms (Cancer) 01/2019
1	Erdheim-Chester Disease 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2018
1	Arteritis 06/2017
1	Pancreatitis 06/2017
1	Inflammation (Inflammations) 01/2014
1	Skin Manifestations 05/2012
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2012
1	Sinusitis 03/2012

Drug/Important Bio-Agent (IBA)

8	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2021 - 05/2012
4	Rituximab (Mabthera)FDA Link 05/2021 - 07/2012
4	Immunoglobulin G (IgG)IBA 01/2019 - 03/2012
3	GlucocorticoidsIBA 01/2020 - 07/2016
2	AllergensIBA 01/2021 - 01/2014
2	Immunoglobulin E (IgE)IBA 01/2021 - 03/2012
2	Immunoglobulin A (IgA)IBA 10/2020 - 03/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2018 - 07/2016
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 09/2013
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 09/2013
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Biological ProductsIBA 11/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	C-Reactive ProteinIBA 01/2018
1	eculizumab FDA Link 09/2017
1	Monoclonal AntibodiesIBA 09/2017
1	Complement System Proteins (Complement)IBA 09/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2014
1	Immunoglobulin M (IgM)IBA 03/2012
1	AntibodiesIBA 03/2012
1	CCR5 Receptors (CCR5 Receptor)IBA 06/2011

Therapy/Procedure

5	Therapeutics 10/2021 - 07/2012
2	Kidney Transplantation 07/2022 - 01/2022
1	Conservative Treatment 10/2021
1	Remission Induction 01/2017